flufenamic acid has been researched along with Acute Lung Injury in 1 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Investigate the effect of flufenamic acid (FFA) on lung injury of sepsis rats." | 7.96 | Flufenamic acid alleviates sepsis-induced lung injury by up-regulating CBR1. ( Chen, Z; Jiang, H; Jiang, Q, 2020) |
| "Investigate the effect of flufenamic acid (FFA) on lung injury of sepsis rats." | 3.96 | Flufenamic acid alleviates sepsis-induced lung injury by up-regulating CBR1. ( Chen, Z; Jiang, H; Jiang, Q, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Q | 1 |
| Chen, Z | 1 |
| Jiang, H | 1 |
1 other study available for flufenamic acid and Acute Lung Injury
| Article | Year |
|---|---|
Flufenamic acid alleviates sepsis-induced lung injury by up-regulating CBR1.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Carbonyl Reductase (NADPH); Cell Line; Flufena | 2020 |